#Fernando #Tatis #Padres #suspended #drug #test
Welcome guys to All Social Updates. Here you can Find complete information about all the latest and important updates about every matter from all around the world. We cover News from every niche whether its big or small. You can subscribe and bookmark our website and social media handles to get the important news fastest before anyone.Follow our website allsocialupdates.com on Facebook, Instagram , Twitter for genuine and real news.
One of Major League Baseball’s smartest and most promising players, Fernando Tatis Jr. of the San Diego Padres, was suspended Friday after testing positive for a performance-enhancing substance. He won’t be able to play this season, essentially. Tatis, a former major leaguer’s son, made his MLB debut in 2019 and won immediate praise on and off the field. He had a.965 OPS and played shortstop and outfield throughout his career. Additionally, he will miss the first 32 games of the upcoming season as well as the balance of the current season due to his suspension, which MLB announced Friday night. The suspension period and return date that we know of is listed below. Clostebol Drug Use and Results by Fernando Tatis Jr. led to an 80-game suspension. The Major League Baseball Commissioner’s Office has imposed an 80-game suspension without pay on San Diego Padres shortstop Fernando Tatis Jr. After testing positive for the performance-enhancing substance Clostebol, he was also suspended for violating Major League Baseball’s Anti-Doping Prevention and Treatment Program. The suspension is effective immediately and prevents the All-Star shortstop from playing in the major leagues this season. According to the statement of the Padres, Fernando Tatis Jr. earned an 80-game ban without pay after testing positive for a performance-enhancing drug in violation of Major League Baseball’s Joint Prevention and Treatment Program. Tatis apologized for his actions, telling the Padres organization, the league, and viewers that it was “my mistake.” “I have no excuse for my oversight, and I would never do anything to cheat or undermine this game that I adore,” Tatis said. I have taken many drug tests in my professional career, including one on March 29, 2022, and they have all come back negative until this one. What Happened to Fernando Tatis Jr.? Tatis broke his left wrist during spring training, forcing him to miss the entire season. The Padres, who are in the playoff hunt, are hoping he will return and boost their chances after starting a rehab assignment in Double-A. The Padres star will not be allowed to play for the Dominican Republic in the March World Baseball Classic, according to MLB, which also claimed the suspension will be indefinite. According to an MLB press release, Tatis tested positive for the steroid Clostebol. He is also the seventh player this season to be suspended for violating the league’s main drug policy. Due to the league’s minor drug rules, 33 players were suspended in total. Players who tested positive for PEDs were also excluded from the postseason that year. Padres general manager AJ Preller insisted he was informed of the ban Friday afternoon. He said he had read the statement from his player but had not yet spoken to Tatis. Padres shortstop won’t be able to play again until 2023 The slugger won’t be able to play again until the 2023 season, according to Marca. In a similar vein, he mentioned in his apology letter his intention to return to the field in 2023. He wrote, “I am very sad.” I would rather be anywhere in the world than being on the field competing with my teammates. He won’t be able to play again until the 2023 campaign. “I initially filed an appeal against the suspension, but after realizing that my mistake caused this result, I decided to immediately start serving it. I can’t wait to join my teammates on the field in 2023.” Tatis will sit out the next 48 regular-season games this season and will finish the remainder of his sentence at the start of next. The Padres’ postseason contests will count toward the 80 games Tatis must miss.